scar preventing would have more attractive market value if it proves working, there are hundreds of millions people badly need this kind of treatment.
Topical application also made it easy to manage for daily usage.
With those positive signs in the P1 trail, which professor Fiona Wood said "unprecedented", it's very encouraging and I am looking forwards to the next announcement about the next trail.
I just couldn't understand the P1 trail design: why did they picked the 13 years old and over 10 cm long scars for the trail?
If they started with much younger and smaller scars, the trial could have been a huge success.
scar preventing would have more attractive market value if it...
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $59.04M | |||
| Open | High | Low | Value | Volume |
| 4.4¢ | 4.4¢ | 4.2¢ | $39.11K | 895.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 752779 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 200000 | 1 |
View Market Depth
| Last trade - 15.58pm 04/10/2024 (20 minute delay) ? |
| SNT (ASX) Chart |